The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
New Funding Opportunities within Myasthenia Gravis Network (GWU, Yale, Duke)
The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers (GW, Yale, Duke) partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.
Pilot research grants: https://www.rarediseasesnetwork.org/mgnet/pilot
Letter of intent due: December 18, 2020
Scholar Program for career development: https://www.rarediseasesnetwork.org/mgnet/scholar
Application Due: November 20, 2020
Duke’s Jeff Guptill, MD, is a member of the executive committee for the network and leads the career enhancement core. The Duke Immune Profiling Core manages the biosamples for the network.
His contact info:
Jeff Guptill, MD, MA, MHS, FAAN
Director, Duke Early Phase Clinical Research Unit
Duke Clinical Research Institute (DCRI)
Department of Neurology - Neuromuscular Medicine
Duke University Medical Center
DCRI Office Phone: 919.668.0504